Delivery Order SPE2DB20D1100-SPE2DB24FE0V5

Award Date 9/27/24
Potential Completion Date 10/21/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $5,688 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 120 mg vials of the specialty medication BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BENLYSTA 400 MG vials. The contract has a ceiling value of $1,259.50 and a period of performance through April 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 400 mg vials of the pharmaceutical BENLYSTA. The contract has a potential value of $1,259.50 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical drug BENLYSTA. The contract has a potential value of $1,259.50 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,259.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was previously awarded to Amerisourcebergen Drug Corp by DLA. The IDC serves as the primary vehicle for...
This is a $7,557 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Benlysta 400 mg vials. The contract has an ultimate completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,259.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BENLYSTA 400 MG vials. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,896.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of BENLYSTA 120 MG VIALS, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
This is a $7,557.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for 400mg vials of the pharmaceutical product BENLYSTA. The delivery order was awarded on August 22, 2024 with an ultimate completion date of September 13, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR pharmaceutical products. The contract has a completion date of February 27, 2024 and a potential value of $2,793.03. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was previously...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FE0V5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a $15,114 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 400 mg vials of the drug BENLYSTA. The contract has an ultimate completion date of October 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a broad range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/27/24, 9:14 AM